CRISPR Therapeutics AG (CRSP) EPS (Diluted) (2016 - 2026)
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) EPS (Diluted) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.13 Bn | 9.29 Bn | 112.79 Mn | 1.79 |
| 2 | CRISPR Therapeutics AG | 5.23 Bn | 5.23 Bn | - | -0.94 |
| 3 | Iovance Biotherapeutics | 3.82 Bn | 3.52 Bn | 55.72 Mn | -0.11 |
| 4 | Legend Biotech | 3.68 Bn | 2.72 Bn | 251.50 Mn | 0.42 |
| 5 | uniQure | 3.08 Bn | 3.08 Bn | 5.49 Mn | -1.22 |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | -1.18 |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | 0.05 |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.54 Bn | 251.87 Mn | -0.05 |
| 9 | Vericel | 2.00 Bn | 1.84 Bn | 56.40 Mn | 0.04 |
| 10 | Taysha Gene Therapies | 1.98 Bn | 1.98 Bn | - | -0.13 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.94 |
| Mar 31, 2026 | -1.28 |
| Dec 31, 2025 | -1.81 |
| Sep 30, 2025 | -1.17 |
| Jun 30, 2025 | -2.40 |
| Mar 31, 2025 | -1.58 |
| Dec 31, 2024 | -0.94 |
| Sep 30, 2024 | -1.01 |
| Jun 30, 2024 | -1.49 |
| Mar 31, 2024 | -1.43 |
| Dec 31, 2023 | 0.74 |
| Sep 30, 2023 | -1.41 |
| Jun 30, 2023 | -0.98 |
| Mar 31, 2023 | -0.67 |
| Dec 31, 2022 | -1.45 |
| Sep 30, 2022 | -2.24 |
| Jun 30, 2022 | -2.40 |
| Mar 31, 2022 | -2.32 |
| Dec 31, 2021 | -1.76 |
| Sep 30, 2021 | -1.67 |